INmune Bio(INMB) - 2024 Q3 - Quarterly Results

Exhibit 99.1 INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinicalstage inflammation and immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2024 and provides a business update. Q3 2024 and Recent Corporate Highlights DN-TNF Platform ...